Related Experiment Video
Updated: Feb 13, 2026

Cochlear Implantation in the Guinea Pig
Published on: June 15, 2018
Development and characterization of a guinea pig model for Marburg virus
Gary Wong1,2,3,4, Wen-Guang Cao1,4, Shi-Hua He1
1Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba R3E 3R2, Canada.
Abstract:
The Angolan strain of Marburg virus (MARV/Ang) can cause lethal disease in humans with a case fatality rate of up to 90%, but infection of immunocompetent rodents do not result in any observable symptoms. Our previous work includes the development and characterization of a MARV/Ang variant that can cause lethal disease in mice (MARV/Ang-MA), with the aim of using this tool to screen for promising prophylactic and therapeutic candidates. An intermediate animal model is needed to confirm any findings from mice studies before testing in the gold-standard non-human primate (NHP) model. In this study, we serially passaged the clinical isolate of MARV/Ang in the livers and spleens of guinea pigs until a variant emerged that causes 100% lethality in guinea pigs (MARV/Ang-GA). Animals infected with MARV/Ang-GA showed signs of filovirus infection including lymphocytopenia, thrombocytopenia, and high viremia leading to spread to major organs, including the liver, spleen, lungs, and kidneys. The MARV/Ang-GA guinea pigs died between 7-9 days after infection, and the LD50 was calculated to be 1.1×10-1 TCID50 (median tissue culture infective dose). Mutations in MARV/Ang-GA were identified and compared to sequences of known rodent-adapted MARV/Ang variants, which may benefit future studies characterizing important host adaptation sites in the MARV/Ang viral genome.
Insights
Researchers developed a Marburg virus variant (MARV/Ang-GA) lethal in guinea pigs. This new model aids in screening Marburg virus therapeutics and understanding viral adaptation for improved disease control.
Area of Science:
- Virology
- Infectious Diseases
- Animal Models
Background:
- The Angolan strain of Marburg virus (MARV/Ang) is highly lethal in humans (up to 90% fatality) but does not cause symptoms in immunocompetent rodents.
- Previous development of a mouse-lethal MARV/Ang variant (MARV/Ang-MA) necessitates an intermediate animal model for preclinical studies before non-human primate testing.
Purpose of the Study:
- To develop and characterize a Marburg virus variant that causes lethal disease in guinea pigs, serving as an intermediate animal model.
- To investigate the pathological features and genetic mutations of the MARV/Ang variant in guinea pigs.
Main Methods:
- Serial passage of the clinical isolate of MARV/Ang in the livers and spleens of guinea pigs.
- Characterization of clinical signs, viremia, organ distribution, and mortality in infected guinea pigs.
- Identification and comparison of mutations in the MARV/Ang-GA variant against known rodent-adapted MARV/Ang strains.
Main Results:
- A MARV/Ang variant (MARV/Ang-GA) emerged, causing 100% lethality in guinea pigs.
- MARV/Ang-GA infection led to typical filovirus symptoms: lymphocytopenia, thrombocytopenia, high viremia, and systemic organ spread.
- The median lethal dose (LD50) of MARV/Ang-GA was determined to be 1.1×10-1 TCID50, with death occurring 7-9 days post-infection.
Conclusions:
- MARV/Ang-GA is a lethal variant in guinea pigs, establishing a valuable intermediate animal model for Marburg virus research.
- This model can facilitate the screening of prophylactic and therapeutic candidates and aid in understanding Marburg virus host adaptation.
Related Concept Videos
What are Viruses?
Sustainable Development
Introduction to Virus
Viruses of Archaea
Viruses with RNA Genomes
Language Development
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...

